MYELODYSPLASTIC SYNDROMES (MDS)
Clinical trials for MYELODYSPLASTIC SYNDROMES (MDS) explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROMES (MDS) trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROMES (MDS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study aims to stop blood cancer return after transplant
Disease control Not yet recruitingThis study compares two ways of giving donor immune cells (DLI) after a stem cell transplant to prevent cancer from coming back in people with hard-to-treat acute myeloid leukemia or myelodysplastic syndromes. About 200 participants will be randomly assigned to receive DLI either…
Matched conditions: MYELODYSPLASTIC SYNDROMES (MDS)
Phase: NA • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated May 17, 2026 04:00 UTC
-
Could a common diabetes pill ease anemia in bone marrow disease?
Symptom relief Not yet recruitingThis study tests if dapagliflozin, a drug used for diabetes and heart failure, can help treat anemia in people with a low-risk form of myelodysplastic syndromes (MDS). Anemia causes tiredness and often requires blood transfusions. The study will give 37 adults the drug daily for …
Matched conditions: MYELODYSPLASTIC SYNDROMES (MDS)
Phase: PHASE2 • Sponsor: Seug yun Yoon, MD • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
New registry to track MDS patients across asia
Knowledge-focused Not yet recruitingThis study is a registry that will gather information from about 500 adults in Asia who have been diagnosed with myelodysplastic syndromes (MDS). The goal is to learn more about the patients' backgrounds, the treatments they receive, and how their disease progresses over time. No…
Matched conditions: MYELODYSPLASTIC SYNDROMES (MDS)
Sponsor: Bristol-Myers Squibb • Aim: Knowledge-focused
Last updated May 13, 2026 15:58 UTC